• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的干预措施提高丙型肝炎病毒感染患者的治疗管理流程。

A Population-Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection.

机构信息

Division of Allergy and Infectious DiseasesUniversity of WashingtonSeattleWAUSA.

Public Health - Seattle King CountySeattleWAUSA.

出版信息

Hepatol Commun. 2020 Nov 7;5(3):387-399. doi: 10.1002/hep4.1627. eCollection 2021 Mar.

DOI:10.1002/hep4.1627
PMID:33681674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7917269/
Abstract

Hepatitis C virus (HCV) infection is common in the United States and leads to significant morbidity, mortality, and economic costs. Simplified screening recommendations and highly effective direct-acting antivirals for HCV present an opportunity to eliminate HCV. The objective of this study was to increase testing, linkage to care, treatment, and cure of HCV. This was an observational, prospective, population-based intervention program carried out between September 2014 and September 2018 and performed in three community health centers, three large multiclinic health care systems, and an HCV patient education and advocacy group in King County, WA. There were 232,214 patients included based on criteria of documented HCV-related diagnosis code, positive HCV laboratory test or prescription of HCV medication, and seen at least once at a participating clinical site in the prior year. Electronic health record (EHR) prompts and reports were created. Case management linked patients to care. Primary care providers received training through classroom didactics, an online curriculum, specialty clinic shadowing, and a telemedicine program. The proportion of baby boomer patients with documentation of HCV testing increased from 18% to 54% during the project period. Of 77,577 baby boomer patients screened at 87 partner clinics, 2,401 (3%) were newly identified HCV antibody positive. The number of patients staged for treatment increased by 391%, and those treated increased by 1,263%. Among the 79% of patients tested after treatment, 95% achieved sustained virologic response. : A combination of EHR-based health care system interventions, active linkage to care, and clinician training contributed to a tripling in the number of patients screened and a more than 10-fold increase of those treated. The interventions are scalable and foundational to the goal of HCV elimination.

摘要

丙型肝炎病毒(HCV)感染在美国很常见,导致了大量的发病率、死亡率和经济成本。简化的筛查建议和高效的直接作用抗病毒药物为消除 HCV 提供了机会。本研究的目的是增加 HCV 的检测、与护理的联系、治疗和治愈。这是一项观察性、前瞻性、基于人群的干预计划,于 2014 年 9 月至 2018 年 9 月在三个社区卫生中心、三个大型多诊所医疗保健系统和华盛顿州金县的 HCV 患者教育和倡导组织中进行。根据有记录的 HCV 相关诊断代码、HCV 实验室检测阳性或 HCV 药物处方,以及在前一年至少在一个参与临床地点就诊一次的标准,共纳入 232214 例患者。创建了电子健康记录(EHR)提示和报告。病例管理将患者与护理联系起来。初级保健提供者通过课堂教学、在线课程、专业诊所跟班学习和远程医疗项目接受培训。在项目期间,有 HCV 检测记录的婴儿潮一代患者的比例从 18%增加到 54%。在 87 家合作诊所筛查的 77577 名婴儿潮一代患者中,有 2401 名(3%)新发现 HCV 抗体阳性。接受治疗的患者人数增加了 391%,接受治疗的患者人数增加了 1263%。在接受治疗后接受检测的 79%的患者中,95%的患者达到了持续病毒学应答。:基于电子健康记录的医疗保健系统干预措施、积极的护理联系和临床医生培训相结合,使筛查患者的人数增加了两倍,接受治疗的患者人数增加了 10 多倍。这些干预措施具有可扩展性,是消除 HCV 的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/10831f399def/HEP4-5-387-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/82f68f066928/HEP4-5-387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/cc62e4a514aa/HEP4-5-387-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/562dacb173e7/HEP4-5-387-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/6c5a682408af/HEP4-5-387-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/10831f399def/HEP4-5-387-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/82f68f066928/HEP4-5-387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/cc62e4a514aa/HEP4-5-387-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/562dacb173e7/HEP4-5-387-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/6c5a682408af/HEP4-5-387-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ebd/7917269/10831f399def/HEP4-5-387-g005.jpg

相似文献

1
A Population-Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection.基于人群的干预措施提高丙型肝炎病毒感染患者的治疗管理流程。
Hepatol Commun. 2020 Nov 7;5(3):387-399. doi: 10.1002/hep4.1627. eCollection 2021 Mar.
2
Improved Hepatitis C Cure Cascade Outcomes Among Urban Baby Boomers in the Direct-Acting Antiviral Era.直接作用抗病毒药物时代城市婴儿潮一代丙型肝炎治愈率的提高。
Public Health Rep. 2020 Jan;135(1):107-113. doi: 10.1177/0033354919888228. Epub 2019 Nov 22.
3
Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.柬埔寨农村地区丙型肝炎的分散检测和治疗:评估整合到现有公共卫生系统中的简化服务模式。
Lancet Gastroenterol Hepatol. 2021 May;6(5):371-380. doi: 10.1016/S2468-1253(21)00012-1. Epub 2021 Mar 19.
4
Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.澳大利亚市中心急诊部门即时检测丙型肝炎病毒和与治疗的衔接
Int J Drug Policy. 2019 Oct;72:84-90. doi: 10.1016/j.drugpo.2019.06.021. Epub 2019 Jul 24.
5
Successful Hepatitis C Birth Cohort Screening and Linkage to Care in a US Community Health System.在美国社区卫生系统中成功进行丙型肝炎母婴传播队列筛查并将其与护理相衔接。
J Public Health Manag Pract. 2022;28(6):E825-E830. doi: 10.1097/PHH.0000000000001590. Epub 2022 Aug 27.
6
Defining the hepatitis C cure cascade in an Urban health system using the electronic health record.利用电子健康记录定义城市卫生系统中的丙型肝炎治愈路径。
J Viral Hepat. 2020 Jan;27(1):13-19. doi: 10.1111/jvh.13199. Epub 2019 Oct 2.
7
Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.药师主导与常规提供的抗病毒治疗在接受阿片类药物替代治疗的丙型肝炎病毒患者中的临床效果:一项实用的、集群随机试验。
Lancet Gastroenterol Hepatol. 2020 Sep;5(9):809-818. doi: 10.1016/S2468-1253(20)30120-5. Epub 2020 Jun 8.
8
Primary Care Evaluation of a Hepatitis C Virus (HCV) Screening Education Intervention.初级保健对丙型肝炎病毒(HCV)筛查教育干预的评估。
J Am Board Fam Med. 2022 Oct 18;35(5):990-997. doi: 10.3122/jabfm.2022.05.210508.
9
Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers.基层医疗中电子健康记录警报对增加婴儿潮一代丙型肝炎筛查和治愈性治疗的影响。
Hepatology. 2017 Dec;66(6):1805-1813. doi: 10.1002/hep.29362. Epub 2017 Sep 14.
10
Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.英国队列中丙型肝炎病毒(HCV)的诊断和治疗途径。
BMC Infect Dis. 2018 Sep 14;18(1):461. doi: 10.1186/s12879-018-3367-3.

引用本文的文献

1
The Impact of New Direct-Acting Antiviral Therapy on the Prevalence and Undiagnosed Proportion of Chronic Hepatitis C Infection in Alberta: A Model-Based Analysis.新型直接抗病毒疗法对艾伯塔省慢性丙型肝炎感染患病率及未诊断比例的影响:基于模型的分析
Can Liver J. 2025 Apr 11;8(2):344-354. doi: 10.3138/canlivj-2024-0062. eCollection 2025 May.
2
Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study.丙型肝炎病毒感染中肝病分期的临床及成本效益:一项微观模拟研究
Clin Infect Dis. 2025 Feb 24;80(2):300-313. doi: 10.1093/cid/ciae485.
3
Racial and Ethnic Disparities in Hepatitis C Care in Reproductive-Aged Women With Opioid Use Disorder.
患有阿片类药物使用障碍的育龄妇女丙型肝炎治疗中的种族和族裔差异。
Clin Infect Dis. 2024 Dec 17;79(6):1428-1436. doi: 10.1093/cid/ciae426.
4
Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference.预防肝细胞癌(HCC)。德克萨斯州协作肝细胞癌(TeCH)多利益相关方会议的白皮书。
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2183-2192. doi: 10.1016/j.cgh.2023.03.029. Epub 2023 Apr 20.
5
Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical Center.南方一所学术医疗中心转诊来源与物质使用情况与丙型肝炎病毒治疗结果的关联
South Med J. 2022 Jun;115(6):352-357. doi: 10.14423/SMJ.0000000000001402.
6
Coordination, Cost, and Changing Epidemiology-Considerations in the Hepatitis C Care Cascade.协调、成本和不断变化的流行病学:丙型肝炎治疗环节中的考虑因素。
Hepatol Commun. 2021 Feb 28;5(3):355-357. doi: 10.1002/hep4.1667. eCollection 2021 Mar.